It is imperative that future research addresses these limitations to enhance the dependability of EPHX2 as a biomarker and to elucidate its involvement in the molecular pathogenesis of renal cell carcinoma. This evidence concerns the gene EPHX2 and hereditary clear cell renal cell carcinoma.